Hot Warren Buffett Stocks To Buy For 2014

In this segment of The Motley Fool's everything-financials show,�Where the Money Is, banking analysts Matt Koppenheffer and David Hanson tell investors what they will be watching when PNC Financial Services (NYSE: PNC  ) , Huntington Bancshares (NASDAQ: HBAN  ) , and KeyCorp� (NYSE: KEY  ) �report earnings this week

David points to the importance of commercial lending, and Matt discusses the potential for lack of earnings-diversity to negatively impact performance.

More outlook on the banking sector from The Motley Fool
Many investors are terrified about investing in banking stocks after the crash, but the sector has one notable stand-out. In a sea of mismanaged and dangerous peers, it rises above as "The Only Big Bank Built to Last." You can uncover the top pick that Warren Buffett loves in The Motley Fool's�new report. It's free, so�click here to access it now.

Top 10 Blue Chip Stocks To Watch Right Now: Medifocus Inc (MDFZF)

Medifocus Inc.(Medifocus) is a Canada-based company. The Company is engaged in the business of development and commercialization of minimally invasive, focused-heat tumor targeted cancer treatment devices and systems. Medifocus operates through its wholly owned subsidiary, Celsion (Canada) Limited (Celsion). Celsion had purchased from Celsion Corporation (United States), all of the assets relating to breast cancer Microfocus APA 1000 System (System), consisting of the microwave machine, the adaptive phased array (APA) technology licensed from Massachusetts Institute of Technology (MIT). The Company focuses on breast cancer treatment by using microwave heating to enhance neoadjuvant chemotherapy to provide tumor shrinkage and control. Advisors' Opinion:

• [By EquityOptionsGuru]

  Over the past few years, and especially months, biotechnology stocks have been soaring on heightened investor expectations. Investors looking for a unique opportunity to participate in a massive bull rally over the next few years might want to pay special attention to one small but growing company called Medifocus (OTCMKTS:MDFZF).

• [By Peter Graham]

  Small cap stocks KBridge Energy Corp (OTCMKTS: BMMCF), Medifocus Inc (OTCMKTS: MDFZF) and Inscor Inc (OTCMKTS: IOGA) have been getting some attention lately in various investment newsletters and some of it is deserved as the first stock sank 35% on Friday, the second one recently released its financials (which did show a big improvement, but there is also a big catch for investors) and the third one has been the subject of a very aggressive promotional campaign. But are any of these three small caps really all that hot for investors? Here is a quick reality check:

Hot Warren Buffett Stocks To Buy For 2014: Oramed Pharmaceuticals Inc (ORMP)

Oramed Pharmaceuticals Inc., incorporated on March 10, 2011, is a development-stage pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet to be used for the treatment of individuals with diabetes, use of orally ingestible capsules, tablets or pills for delivery of other polypeptides. The Company owns oral dosage form drug portfolio, it is, on an on-going basis, considering in-licensing and other means of obtaining additional technologies to complement and/or expand the product portfolio. The Company�� products include ORMD-0801 - Oral Insulin Capsule and ORMD-0901 - Oral Exenatide.

The Company focuses to conduct research and development on the technology covered by the patent application Methods and Composition for Oral Administration of Proteins. Through its research and development efforts, it focuses to develop an oral dosage form that will withstand the chemical environment of the stomach and intestines and will be effective in delivering active insulin for the treatment of diabetes. It intends to conduct the clinical trials to file an Investigational New Drug (IND), application with the United States Food and Drug Administration (FDA). It also focuses to conduct research and development by deploying its drug delivery technology for the delivery of other polypeptides in addition to insulin, and to develop other pharmaceutical products.

Advisors' Opinion:

• [By Lisa Levin]

  Oramed Pharmaceuticals (NASDAQ: ORMP) shares moved up 21.26% to $14.20. The volume of Oramed Pharmaceuticals shares traded was 621% higher than normal. Oramed shares have jumped 187.01% over the past 52 weeks, while the S&P 500 index has gained 28.75% in the same period.

• [By Ben Levisohn]

  Oramed Pharmaceuticals (ORMP) has dropped 19% to $12.11 after the company said it would sell nearly 1.6 million shares of stock for $10 a share.

  BP plc (BP) has fallen 0.7% to $47.24 after a U.S. judge refused its request to revise the way damages from the Deepwater Horizon oil spill are calculated.

Hot Warren Buffett Stocks To Buy For 2014: Abbott Laboratories(ABT)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company offers adult and pediatric pharmaceuticals for rheumatoid and psoriatic arthritis, ankylosing spondylitis, psoriasis, and Crohn's disease; dyslipidemia; HIV infection; prostate cancer, endometriosis and central precocious puberty, and anemia caused by uterine fibroids; respiratory syncytial virus; adult males who have low or no testosterone; secondary hyperparathyroidism; hypothyroidism; and pancreatic exocrine insufficiency, as well as anesthesia products. It also provides diagnostic products, such as immunoassay systems; chemistry systems; assays used for screening and/or diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, physiological, and infectious diseases; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infections agents; genomic-b ased tests; hematology systems and reagents; and point-of-care diagnostic systems and tests for blood analysis. In addition, the company offers a line of pediatric and adult nutritional products. Further, it provides coronary, endovascular, vessel closure, and structural heart devices, such as drug-eluting stent systems, coronary metallic stents, balloon dilatation products, coronary guidewires, vessel closure devices, carotid stent systems, percutaneous valve repair systems, and drug eluting bioresorbable vascular products. Additionally, the company provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products, as well as branded generic pharmaceutical products. Abbott primarily serves retailers, wholesalers, hospitals, and health care facilities. Abbott was founded in 1888 and is headquartered in Abbott Park, Illinois.

Advisors' Opinion:

• [By Jim Jubak]

  Six milk powder producers, charged by China's National Development and Reform Commission with price fixing, have pled guilty and will be fined 669 million yuan ($109 million.) The companies—Mead Johnson Nutrition (MJN), Danone (DANOY) subsidiary Dumex, Abbott Laboratories (ABT), Fonterra Cooperative Group (FSF:AU), FrieslandCampina, and Biostime International Holdings—admitted they set minimum prices for distributors in order to keep prices high. Many of the companies had earlier cut the prices they charge in China—Fonterra had cut the price of its Anmun brand of baby formula 9%, Abbott Laboratories had reduced prices by as much as 12%, and Mead Johnson had lowered prices by 7% to 15%. This is, CaixinOnline reports, the harshest penalty handed out under China's five-year-old anti-monopoly law. The announcement of the fine, hard on the heels of a ban by China on all imports of whey protein products from Fonterra—after regulators found a batch of whey from a Fonterra plant in New Zealand contaminated with botulism—makes it clear that something big is going on here.

• [By Victor Selva]

  As we can see, the firm has a lower ROE than Abbott Laboratories (ABT), Thermo Fisher Scientific Inc. (TMO) and CVS Caremark Corporation (CVS).

  Final Comment

• [By Jim Jubak]

  Fourth quarter earnings and guidance for 2014, announced on January 22, make it clear that Abbott Laboratories (ABT) is a second half story for 2014.

Hot Warren Buffett Stocks To Buy For 2014: Stage Stores Inc.(SSI)

Stage Stores, Inc. operates as a specialty department store retailer that offers branded and private label apparel, accessories, cosmetics, and footwear for women, men, and children in the United States. The company also offers sportswear, dresses, intimates, home and gift products, outerwear, swimwear, and other products. It primarily focuses on consumers in small and mid-sized markets. The company operates stores under the names of Bealls, Goody?s, Palais Royal, Peebles, and Stage. Stage Stores, Inc. also sells its products through its Web site. As of March 06, 2012, it operated 819 stores in 40 states. Stage Stores, Inc. is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Stage Stores (NYSE: SSI) was also up, gaining 13.47 percent to $22.41 after the company reported Q4 results and announced the sale of its Steele's off-price division to a new retail unit of Hilco Global.

• [By Anna Prior]

  Stage Stores Inc.(SSI) said it agreed to sell its Steele’s retail stores to financial services firm Hilco Global later this year, which contributed to a drop in fiscal fourth-quarter earnings. The top line missed expectations, and the sales view for the year also fell below the consensus view.

• [By Dan Caplinger]

  On Friday, Stage Stores (NYSE: SSI  ) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting earnings is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news that turns out to be exactly the wrong move.

Hot Warren Buffett Stocks To Buy For 2014: ChinaCache International Holdings Ltd.(CCIH)

ChinaCache International Holdings Ltd. provides Internet content and application delivery services to businesses, government agencies, and enterprises in China. It offers Web Page Content Services to website operators; file transfer services; rich media streaming services that enable live streaming of media files; guaranteed application services for websites that incorporate applications with features, such as on-line booking and ordering, real-time stock quotes, and on-line surveys; managed internet data services; ChinaCache cloud services; and content bridging services. The company also provides various value-added services, such as geo-content acceleration services, performance evaluation module, scalable services routing services, link anti-hijack services, NetStorage services, user behavior analysis services, and Website performance evaluation services. The company was founded in 1998 and is headquartered in Beijing, the People?s Republic of China.

Advisors' Opinion:

• [By CRWE]

  ChinaCache International Holdings Ltd. (Nasdaq:CCIH), the leading total solutions provider of internet content and application delivery services in China, reported that it will participate in Cowen and Company’s 40th Annual Technology, Media & Telecom Conference in New York, on May 31, 2012 at 12:30PM ��1:10PM local time.

• [By Eric Volkman]

  ChinaCache International Holdings (NASDAQ: CCIH  ) wants to spend money on its own shares after all. The company announced that its board has authorized a resumption of its stalled $10 million American Depositary Shares buyback program. It has plenty left in the tank. When halted, ChinaCache had spent only $1.5 million on such purposes.